Concepts in receptor optimization: Targeting the RGD peptide

被引：0
|
作者：
Chen, Wei [1 ]
Chang, Chia-En [1 ,2 ]
Gilson, Michael K. [1 ]
机构：
[1] Center for Advanced Research in Biotechnology, University of Maryland Biotechnology Institute, 9600 Gudelsky Drive, Rockville, MD 20850, United States
[2] Department of Chemistry and Biochemistry, University of California, San Diego, San Diego, CA, United States
来源：
Journal of the American Chemical Society | 2006年 / 128卷 / 14期
关键词：
Synthetic receptors have a wide range of potential applications; but it has been difficult to design low molecular weight receptors that bind ligands with high; proteinlike affinities. This study uses novel computational methods to understand why it is hard to design a high-affinity receptor and to explore the limits of affinity; with the bioactive peptide RGD as a model ligand. The M2 modeling method is found to yield excellent agreement with experiment for a known RGD receptor and then is used to analyze a series of receptors generated in silico with a de novo design algorithm. Forces driving binding are found to be systematically opposed by proportionate repulsions due to desolvation and entropy. In particular; strong correlations are found between Coulombic attractions and the electrostatic desolvation penalty and between the mean energy change on binding and the cost in configurational entropy. These correlations help explain why it is hard to achieve high affinity. The change in surface area upon binding is found to correlate poorly with affinity within this series. Measures of receptor efficiency are formulated that summarize how effectively a receptor uses surface area; total energy; and Coulombic energy to achieve affinity. Analysis of the computed efficiencies suggests that a low molecular weight receptor can achieve proteinlike affinity. It is also found that macrocyclization of a receptor can; unexpectedly; increase the entropy cost of binding because the macrocyclic structure further restricts ligand motion. © 2006 American Chemical Society;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Journal article (JA)
引用
收藏
页码：4675 / 4684
相关论文
共 50 条
  • [31] Targeting the insulin receptor with hormone and peptide dimers
    Lin, Jingjing
    Selicharova, Irena
    Mitrova, Katarina
    Fabre, Benjamin
    Miriyala, Vijay Madhav
    Lepsik, Martin
    Jiracek, Jiri
    Hernandez, Maria Soledad Garre
    JOURNAL OF PEPTIDE SCIENCE, 2023, 29 (04)
  • [32] Preparation and characterization of a dual-receptor mesoporous silica nanoparticle-hyaluronic acid-RGD peptide targeting drug delivery system
    Xu, Haixing
    Wang, Zhihui
    Li, Yan
    Guo, Yufeng
    Zhou, Huimin
    Li, Yiping
    Wu, Fengzheng
    Zhang, Lingxi
    Yang, Xiawen
    Lu, Bo
    Huang, Zhijun
    Xu, Wenjin
    Xu, Peihu
    RSC ADVANCES, 2016, 6 (46): : 40427 - 40435
  • [33] Evaluation of targeting αVβ3 in breast cancers using RGD peptide-based agents
    Josefsson, Anders
    Yu, Jing
    Majumdar, Sunipa
    Bhise, Abhinav
    Hobbs, Robert F.
    Nedrow, Jessie R.
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 128
  • [34] Design of integrin αvβ3 targeting self-assembled protein nanoparticles with RGD peptide
    Lv, Xiangfeng
    Zhang, Chun
    Shuaizhen, Qingyun
    Yu, Rong
    Zheng, Yongxiang
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 128
  • [35] Gold Nanoparticles Capped by a GC-Containing Peptide Functionalized with an RGD Motif for Integrin Targeting
    Scari, Giorgio
    Porta, Francesca
    Fascio, Umberto
    Avvakumova, Svetlana
    Dal Santo, Vladimiro
    De Simone, Mariarosaria
    Saviano, Michele
    Leone, Marilisa
    Del Gatto, Annarita
    Pedone, Carlo
    Zaccaro, Laura
    BIOCONJUGATE CHEMISTRY, 2012, 23 (03) : 340 - 349
  • [36] 177Lu-labeled RGD-BBN heterodimeric peptide for targeting prostate carcinoma
    Jiang, Lei
    Miao, Zheng
    Liu, Hongguang
    Ren, Gang
    Bao, Ande
    Cutler, Cathy S.
    Shi, Hongcheng
    Cheng, Zhen
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (09) : 909 - 914
  • [37] DEVELOPMENT OF A SMALL RGD PEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST WITH POTENT ANTIAGGREGATORY ACTIVITY INVITRO
    SAMANEN, J
    ALI, F
    ROMOFF, T
    CALVO, R
    SORENSON, E
    VASKO, J
    STORER, B
    BERRY, D
    BENNETT, D
    STROHSACKER, M
    POWERS, D
    STADEL, J
    NICHOLS, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (10) : 3114 - 3125
  • [38] A novel peptide targeting gastrin releasing peptide receptor for pancreatic neoplasm detection
    Tu, Yuanbiao
    Tao, Ji
    Wang, Fang
    Liu, Peifei
    Han, Zhihao
    Li, Zhaolun
    Ma, Yi
    Gu, Yueqing
    BIOMATERIALS SCIENCE, 2020, 8 (09) : 2682 - 2693
  • [39] Investigation of bombesin peptide as a targeting ligand for the gastrin releasing peptide (GRP) receptor
    Begum, Anjuman Ara
    Moyle, Peter M.
    Toth, Istvan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (22) : 5834 - 5841
  • [40] Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles
    Su, Gaoxing
    Jiang, Huaqiao
    Xu, Bohui
    Yu, Yanyan
    Chen, Xueqin
    MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5019 - 5030
12345